Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

59917-39-4

Vindesine sulfate

59917-39-4
93413-69-5

Venlafaxine-D,L

93413-69-5
137862-53-4

Valsartan

137862-53-4
99300-78-4

Venlafaxine-D,L HCl

99300-78-4
125317-39-7

Vinorelbine Ditartrate

125317-39-7
175865-59-5

Valganciclovir HCl

175865-59-5
152-11-4

Verapamil HCl

152-11-4
676129-92-3

Des(oxopentyl) Valsartan

676129-92-3
1111177-24-2

Des(oxopentyl) Valsartan Methyl Ester

1111177-24-2
133868-46-9

Valnemulin HCl

133868-46-9
21411-53-0

Virginiamycin M1

21411-53-0
960203-27-4

Vortioxetine HBr

960203-27-4
443913-73-3

Vandetanib

443913-73-3
918504-65-1

Vemurafenib

918504-65-1
330808-88-3

Vardenafil Hydrochloride trihydrate

330808-88-3
71109-09-6

Vedaprofen

71109-09-6
23152-29-6

Virginiamycin S1

23152-29-6
3681-93-4

Vitexin

3681-93-4
274901-16-5

Vildagliptin

274901-16-5
24356-66-9

Vidarabine Monohydrate

24356-66-9